PRESS RELEASE Lund, September 21st, 2026
Preview text: PRESS RELEASE Lund, September 21st, 2026
Image not available
No image available for this email.
- Subject
- PRESS RELEASE Lund, September 21st, 2026
- Preview text
- PRESS RELEASE Lund, September 21st, 2026
- From
- info@
hamletbiopharma.com - Brand
- Hamlet BioPharma
- ESP
- Mailchimp
- Sent
- Mon Sep 21, 2026, 4:39 AM ET
- Size
- 55 KB
- Images
- 8
- Links
- 8, 2 of them buttons
- Subject length
- 40 characters
Against Hamlet BioPharma's usual
Sent in its busiest hour, 4 AM, which holds 17% of its emails. The subject is 40 characters; its average is 45.
Sent just before and after
| Oct 23, 2026 3:00 AM | Kallelse till årsstämma Hamlet BioPharma AB – 20 November 2026 | |
| Sep 24, 2026 7:56 AM | Hamlet Biopharma Is Profiled On ‘’The Bio Report’’, One Of The Leading Biotech Podcasts In The World | |
| Sep 21, 2026 11:07 AM | BAMLET treatment strengthens metabolic health | |
| Sep 21, 2026 4:39 AM | PRESS RELEASE Lund, September 21st, 2026 (this email) | |
| Sep 17, 2026 3:38 AM | PRESS RELEASE – Lund, September 17th 2026 | |
| Aug 28, 2026 3:15 AM | Hamlet BioPharma – Year-end Report (Q4) July 2025 – June 2026 | |
| Aug 27, 2026 6:15 AM | Hamlet BioPharma bjuder in till pressträff den 28 augusti 2026 |
More from Hamlet BioPharma
All Hamlet BioPharma emailsNov 9, 2026 5:45 AM
Hamlet BioPharma publicerar årsredovisning 2025/2026
Oct 30, 2026 4:01 AM
PRESS RELEASE Lund, October 28th, 2026
Oct 28, 2026 6:09 AM
